Cited by 33Muscle Physiology and DisordersMitochondrial Function and PathologyAdipose Tissue and Metabolism

Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy

Open access
Venhoff, Nils, Lebrecht, Dirk, Pfeifer, Dietmar, Venhoff, Ana C, Bissé, Emmanuel, Kirschner, Janbernd, Walker, Ulrich A·2012·Arthritis Research & Therapy

Abstract

Introduction: Skeletal muscle fiber composition and muscle energetics are not static and change in muscle disease. This study was performed to determine whether a mitochondrial myopathy is associated with adjustments in skeletal muscle fiber-type composition. Methods: Ten rats were treated with zidovudine, an antiretroviral nucleoside reverse transcriptase inhibitor that induces a myopathy by interfering with mitochondrial functions. Soleus muscles were examined after 21 weeks of treatment. Ten untreated rats served as controls. Results: Zidovudine induced a myopathy with mitochondrial DNA depletion, abnormalities in mitochondrial ultrastructure, and reduced cytochrome c oxidase activity. Mitochondrial DNA was disproportionally more diminished in type I compared with type II fibers, whereas atrophy predominated in type II fibers. Compared with those of controls, zidovudine-exposed soleus muscles contained an increased proportion (256%) of type II fibers, whereas neonatal myosin heavy chains remained repressed, indicating fiber-type transformation in the absence of regeneration. Microarray gene-expression analysis confirmed enhanced fast-fiber isoforms, repressed slow-fiber transcripts, and reduced neonatal fiber transcripts in the mitochondrial myopathy. Respiratory chain transcripts were diminished, whereas the enzymes of glycolysis and glycogenolysis were enhanced, indicating a metabolic adjustment from oxidative to glycolytic capacities. A coordinated regulation was found of transcription factors known to orchestrate type II fiber formation (upregulation of MyoD, Six1, Six2, Eya1, and Sox6, and downregulation of myogenin and ERRγ). Conclusions: The type I to type II fiber transformation in mitochondrial myopathy implicates mitochondrial function as a new regulator of skeletal muscle fiber type.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/ar4076

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Venhoff, N., Lebrecht, D., Pfeifer, D., Venhoff, A. C., Bissé, E., Kirschner, J., & Walker, U. A.
Affiliations
  • University Medical Center Freiburg (DE)
  • University of Basel (CH)
Corresponding author
  • Venhoff, Nils
  • Walker, Ulrich A
Venue
Arthritis Research & Therapy
Published
2012-10-29
Volume
14
Issue
5
Pages
R233-R233
ISSN
1478-6354 (ISSN-L)
OpenAlex
W2021882159
Cited by
33
References
56
Citations by year
2026: 2 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 1
FWCI
0.51
Type
journal article
Language
en
Open access
Locations
  • Arthritis Research & Therapy (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
mitochondrial myopathy, skeletal muscle fiber type composition, mitochondrial DNA depletion, cytochrome c oxidase deficiency, soleus muscle, neonatal myosin heavy chain, glycolytic metabolism, transcription factors, MyoD, Six1, Six2, EYA1, SOX6, estrogen-related receptor gamma, myogenin, mitochondrial function
MeSH terms
Animals, Disease Models, Animal, Electron Transport, Male, Mitochondria, Muscle, Muscular Atrophy, Muscular Diseases, Zidovudine, Rats, Wistar, Muscle, Skeletal, Muscle Fibers, Fast-Twitch, Muscle Fibers, Slow-Twitch, Reverse Transcriptase Inhibitors, Rats, Cell Transdifferentiation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review